Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT07838675

MediPD: An Online Mediterranean Diet Program for People Living With Parkinson’s Disease

MediPD: An Online Mediterranean Diet Program for People Living With Parkinson’s Disease — Recruiting • Non-phase study • Neurology • NCT07838675.

📅 21 Oct 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07838675
Sponsor
Queen's University, Belfast
Start
2026-10-10
ClinicaliQ Trial Snapshot
  • MediPD: An Online Mediterranean Diet Program for People Living With Parkinson’s Disease — Recruiting • Non-phase study • Neurology • NCT07838675.
  • What is being tested: MediPD, an online Mediterranean diet intervention programme designed specifically for people living with Parkinson's disease, with evaluation of its acceptability, feasibility, and effectiveness in supporting sustained dietary behaviour change.
  • Patient eligibility overview: The study includes people living with Parkinson's disease who are able to participate in an online programme; specific inclusion/exclusion criteria would be detailed in the full protocol regarding disease stage, cognitive function, and internet access requirements.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The aim of this pilot study is to assess whether an online Mediterranean diet programme called MediPD is acceptable and practical for people living with Parkinson's disease, and whether it can help them make and maintain changes towards a Mediterranean-style diet. The study will include 120 adults living in the United Kingdom with Parkinson's disease who have access to an internet-enabled device and currently have low adherence to a Mediterranean-style diet. Participants will be randomly assigned to one of two groups. One group will receive access to the MediPD online…

Eligibility Snapshot
  • : * Self-reported idiopathic Parkinson's disease * Age 18 years or older * Community-dwelling and resident in the United Kingdom * Access to an internet-enabled device and an active email address * Mediterranean Diet Score ≤7/13, indicating low adherence to a Mediterranean diet * Proficient in English * Able to provide informed consent

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Smart beds and motion sensors – is this the future of dementia care?
Neurology · BBC Health · 20 Sep 2026
Key takeaways for clinical practice: Smart home technology including motion sensors, bed monitors, and wearable devices (socks) can enable remote monitoring of…
View brief →
Guideline
Mirdametinib for treating symptomatic and inoperable plexiform neurofibromas associated with neurofibromatosis type 1 in people 2 to 17 years
Neurology · 16 Sep 2026
Mirdametinib is indicated for symptomatic and inoperable plexiform neurofibromas in children aged 2-17 years with neurofibromatosis type 1 (NF1); confirm diagnosis and…
View guideline →
Clinical Brief
My daughter has childhood dementia and may not live past 16
Neurology · BBC Health · 01 Apr 2026
Key Clinical Takeaways Childhood dementia represents a group of rare progressive neurodegenerative disorders with devastating outcomes—Sophia's case illustrates the severe functional decline…
View brief →
Clinical Brief
Families hit by long waits for dementia diagnosis
Neurology · BBC Health · 02 Sep 2026
Dementia diagnosis delays are widespread, with patients experiencing waits of months to years, creating prolonged uncertainty for families during a critical period…
View brief →
Guideline
Dementia: Assessment, Management and Support (NICE NG97)
Neurology · 25 Mar 2026
Use cognitive testing (MMSE or MoCA) combined with appropriate imaging to confirm dementia diagnosis • Prescribe acetylcholinesterase inhibitors (donepezil, rivastigmine, or galantamine)…
View guideline →
Clinical Brief
Diabetes and ADHD drugs to be tested on Alzheimer’s patients in new study
Neurology · BBC Health · 21 Oct 2026
Diabetes and ADHD medications are being simultaneously tested as potential Alzheimer's treatments, potentially accelerating drug development timelines for this common dementia type…
View brief →